laboratory for targeted drug delivery & personalized medicine technologies
Our research group is aimed at improving patients’ quality of life and bettering their treatment by developing innovative medical technologies. Specifically, we focus on targeting metastatic cancer with nanotechnology, and on constructing miniature medical devices that couple diagnosis to therapy (theranostic devices). Our lab is headed by Dr Avi Schroeder, who has years of experience in nanotechnology and personalized medicine.
Dr. Avi Schroeder has translational experience with the development of liposome-based clinical systems. He is the author of scientific papers in the field of nanotechnology and medicine. Schroeder is the inventor on 14 patents, and recipient of 20 national and international innovation awards. Dr. Schroeder is a scientific-entrepreneur, starting 5 successful Technion spin-outs.
Our research is supported by:
Phospholipids Research Center
Israel Innovation Authority
Israel Science Foundation - ISF
Years of Experience
Avi received all three degrees in Chemical Engineering from the Ben-Gurion University. His postdoctoral training at the Massachusetts Institute of Technology (2012). At MIT, Avi and colleagues developed nanoparticles that are capable of autonomously synthesizing proteins upon signal, thereby being a platform for on-site delivery of drugs and preventing damage to healthy organs. In our lab, Avi is building an expert team to work towards improved personalized and targeted medicine.
Janna received her B.Sc. in Biotechnology and Food Engineering from the Technion-Israel Institute of Technology (2007)... She completed her PhD studies under the supervision of Prof. Ayelet Fishman in the same department. Her research focused on production of valuable chiral sulfoxides using oxidizing enzymes. Janna joined Dr. Schroeder’s group and serves as a lab director and senior scientist, involved in many projects in the lab.
Jeny received BA, MSc and PhD from the Technion. During her PhD obtained under the supervision of Dr. Estee Kurant, she focused on processes involved in dead cells removal at the embryonic central nervous system. In her postdoc at Griffiths lab in UCDAVIS she investigated different aspects of endothelial cells recellularization of xenogeneic scaffolds and development of a novel antigen removal method. Jeny joined Schroeder group in 2019 and serves as lab manager and senior scientist.
Hila received her PhD in Biotechnology and Food engineering in 2018. Her PhD focused on the effects of genetics, nutrition, and carriage to pathogenic antibiotic-resistant bacteria on the microbiome, under the supervision of Prof. Yechezkel Kashi. In her postdoc, she managed the development of a prediction method for food spoilage combining big data and hyper-spectral imaging. Hila joined the lab in 2020 and is leading a team developing an oral delivery system in a “food as medicine” approach.
Hanan graduated from the Hebrew University with a MSc in Pharmaceutical Sciences, gaining two Excellence Awards for her work. Hanan is completing her PhD in our group, focusing on targeting the tumor microenvironment with nanotechnology.
Omer received his BSc in biochemical engineering at the Technion (2017). Omer worked as an undergraduate research student in the lab for 3 years focusing on proteolytic enzyme delivery for tissue manipulation. In his current PhD research, Omer is focusing on development of synthetic cells and cell-free protein synthesis systems.
Maria received her BSc in Biochemical engineering from the Technion (2017). Maria joined the team in 2015 to work as an undergraduate student. In her current research she is developing a nano-scale platform to study single-cell drug resistance.
Mohammed received his B.Sc in pharmaceutical engineering from Azrieli college of engineering (2014). He completed his MSc studies under the supervision of Prof. Avi Domb at the Hebrew University in Medicinal Chemistry (2017). Mohammed is completing his PhD studies in our group, focusing on active targeting of Head and neck cancer using nanotechnology.
Maya received her B.Sc in Biotechnology and Food Engineering from the Technion (2017). Maya joined our lab in August 2015, and together with Nitzan developed protein producing particles for onsite drug delivery. In her current PhD research, Maya is focusing on targeting neurons at the tumor microenvironment with nanotechnology.
Gal received her B.Sc in Biochemical engineering from the Technion (2018). Gal joined the lab as an undergarduate researcher in September 2017 and participated in the synthetic cell system development. In her current M.Sc. research, Gal continues to work on the development of the synthetic cell system as a base for therapeutic applications.
Aviram received his B.Sc. in Biochemical Engineering from the Technion (2018). Aviram started working at the lab in March 2018 as a part of collaboration with a lab from the Hebrew University. Aviram’s current study focuses on developing new generation of RNA delivery systems.
Mor received her B.Sc in Chemistry from the Ben-Gurion University of the Negev (2019). Mor joined our lab in October 2018, and together with Maya Kaduri (Ph.D. student) developed a system for targeting neurons at the breast tumor microenvironment with nanotechnology. Mor is focusing on liposomal active targeted drug delivery system to the Central Nervous System.
Noga received her B.Sc in Biochemical Engineering at the Technion (2016). Noga has been working for 3 years as R&D engineer in NanoSpun Technologies and has joined the team in February 2019. In her current M.Sc research, Noga is focusing on designing synthetic cells system as a base for therapeutic applications.
Ravit is a MSc student, in parallel to her last semester as a BSc student in chemical engineering at the Technion. Ravit joined the team in 2018 as an undergraduate research student, focusing on synthetic cells and cell-free protein synthesis systems. In her current research, she is developing radio frequency stimuli responsive nanoparticles.
Egor received his integrated BSc and MSc degree in Medical Biochemistry at The University of Manchester (2019). He completed his MSc studies under the supervision of Prof. Stephen Taylor at the MCRC, The University of Manchester (2019). Egor joined the lab in January 2020 and is currently studying towards an MSc degree in Nanotechnology. Egor's work is centred on the creation of liposomal and polymeric formulations for DNA and RNA delivery to cells using manual and automated approaches.
Adi is a research assistant at Schroeder's lab. He received his B.Sc. in Biotechnology and Food Engineering from the Technion in 2017. He brings three years of experience from the biotech industry in molecular microbiology. Adi joined the lab at 2021 and he is a part of the team developing an oral delivery system in a “food as medicine” approach.